OxiGene Inc (OXGN)

0.71
0.06 9.23
NASDAQ : Health Care
Prev Close 0.65
Open 0.67
Day Low/High 0.67 / 0.72
52 Wk Low/High 0.49 / 1.40
Volume 135.33K
Avg Volume 534.20K
Exchange NASDAQ
Shares Outstanding 26.54M
Market Cap 18.58M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
ESMO Preview: Cancer Stocks to Watch

ESMO Preview: Cancer Stocks to Watch

A key European cancer research meeting this week will include drug presentations from Dendreon, Amgen, ImmunoGen and others.

SinoCoking Coal, Oxigene: Volume Movers

SinoCoking Coal, Oxigene: Volume Movers

Several stocks trading below $10, including SinoCoking Coal, were moving on above-average volume Monday.

Oxigene: Stock Up On Mixed Cancer Data

Oxigene's thyroid cancer drug boost survival but study results marred by too few patients and lack of statistical significance.

Trubion, ShoreTel: Volume Movers

Trubion, ShoreTel: Volume Movers

Several stocks trading below $5, including Trubion Pharmaceuticals, were poised to move on above-average volume Friday.

8 Penny Stocks Get Delisting Warning

8 Penny Stocks Get Delisting Warning

Another eight small-cap companies are on watch by the Nasdaq to be delisted in six months.

OXiGENE Completes Enrollment Of ZYBRESTAT Phase 2 Trial In Non-Small Cell Lung Cancer

Encouraging Safety and Outcome Data Recently Reported at the 2010 ASCO Annual Meeting

Biotech Stock Mailbag: ASCO

Biotech Stock Mailbag: ASCO

Adam Feuerstein answers readers' questions about health care- and drug-related companies.

The ASCO Weekend Live Blog Recap

The ASCO Weekend Live Blog Recap

Highlights from Adam Feuerstein's live coverage of the ASCO annual meeting Saturday and Sunday.

ASCO Live Blog: Sunday

Here are the highlights from the second full day of clinical data presentations at ASCO 2010.

Oxigene Says Laffer Resigned From Its Board

Oxigene Says Laffer Resigned From Its Board

Oxigene says Arthur Laffer resigned from the board of directors to pursue other interests

Top Takes From RealMoney

Top Takes From RealMoney

Here's what some of our market pros are saying and playing.

Small-Cap Biotechs Pop Before Conference

Small-Cap Biotechs Pop Before Conference

Small-cap cancer drugs get a lift before the American Society of Clinical Oncology's annual meeting.

Monday's Health Winners & Losers

Monday's Health Winners & Losers

IDM Pharma's new year's resolution is to restructure.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

Dade Behring soars on acquisition news.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

OxiGene is on the rise.